Timeline
Last
$877.23
+46.80 (5.64%)
24HR+5.6%
1W-1.3%
1M+11.9%
1Y+24.6%
Valuation
- Market Cap
- —
- Enterprise Value
- $111.6B
- P/E (TTM)
- 22.86x
- Forward P/E
- 17.41x
- Price / Sales
- —
- EV / EBITDA
- 16.21x
Cash Flow
- Operating Cash Flow
- $6.2B
- Free Cash Flow
- $5.7B
- FCF Margin
- 1.4%
- Cash Conversion
- 91.9%
- Cash / Share
- $33.1
Margins & Growth
- Gross Margin
- 3.6%
- Operating Margin
- 2.2%
- EBITDA Margin
- 1.7%
- Net Margin
- 1.2%
- Revenue Growth
- 6.0%
- Earnings Growth
- 37.2%
Balance Sheet
- Total Cash
- $4B
- Total Debt
- $8.8B
- Net Cash
- -$4.8B
- Debt / Equity
- —
- Current Ratio
- 0.85x
- Quick Ratio
- 0.48x
Returns & Ownership
- Return on Assets
- 5.0%
- Return on Equity
- —
- Dividend Yield
- 0.4%
- Payout Ratio
- 8.3%
- Beta
- 0.31
- Institutional Ownership
- 94.7%
Latest EPS$9.93+0.0% surprise
Beat rate100%4 print streak
Avg surprise+0.0%vs consensus
Next printAug 5, 2026EPS $10.76
Quarterly EPS vs consensus
4 quarters Actual ConsensusLabels: beat $ · YoY %Revisions 11 up / 11 down
Earnings transcripts
Read management commentary and analyst Q&A.
No transcript dates are available yet for this ticker.
Forward estimates
Consensus expectations and estimate momentum.
PeriodEPSRevenueGrowth
0QSep 2026
$10.76$109.9B+9.1%+1QDec 2026
$11.06$113.5B+18.5%0YMar 2027
$44.25$431.2B+13.1%+1YMar 2028
$50.38$463.5B+13.8%Primary research
Recent company filings
Jump directly to earnings releases, quarterly reports, and material updates.
10-QPeriodic Financial Reports2026-08-058-KCorporate Changes & Voting Matters2026-07-248-KCorporate Changes & Voting Matters2026-07-0110-KPeriodic Financial Reports2026-05-088-KCorporate Changes & Voting Matters2026-05-078-KCorporate Changes & Voting Matters2026-04-288-KCorporate Changes & Voting Matters2026-04-068-KCorporate Changes & Voting Matters2026-03-068-KCorporate Changes & Voting Matters2026-03-058-KCorporate Changes & Voting Matters2026-02-0410-QPeriodic Financial Reports2025-11-068-KCorporate Changes & Voting Matters2025-11-05
MCK stock research · McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products t…
| Last price | $877.2 |
|---|---|
| Day change | +46.80 (5.64%) |
| Market cap | — |
| P/E (TTM) | 22.86x |
| Sector | Healthcare |
| Industry | Medical Distribution |